Government data and research point to a long decline in US corporate investment in upstream research. At the same time, the ratio of federal government R&D spending to GDP is at its lowest level since the early 1950s. How pervasive are these trends across countries, fields, technologies, industries, and firms of different sizes? Are corporate trends explained by global competition, financial market pressures, or other factors? Are there reasons policymakers should be concerned?

Senator Chris Coons (D-Del.) delivers a speech detailing his concerns about the PTAB process.

The Duke Law Center for Innovation Policy hosted a roundtable in Washington, D.C., on June 3, 2015. Experts from academia, government, and the private sector discussed and critiqued the Patent Trial and Appeal Board (PTAB) process, instituted in 2012 as an alternative to costly district court litigation over patent validity.